#ICYMI THE NEW GASTROENTEROLOGIST's overview of therapeutic management of #NAFLD ms.spr.ly/6012jb7gI

The real competition in medicine is not between companies. Rather it's us against disease. ms.spr.ly/6016jjBw6 #Changemakers via Dr. John Whyte

Adding high-dose vitamin C to first-line chemotherapy does not significantly improve PFS in patients with mCRC but may benefit patients with RAS mutation. ms.spr.ly/6011jj19c

Select chemopreventive agents may effectively decrease the incidence of precursor colorectal adenomas, thus lowering the future burden of CRC. ms.spr.ly/6017jj16l

A live birth after the diagnosis of BC does not have a negative impact on a woman’s OS. ms.spr.ly/6019jjjIR

People exposed to high levels of PFOS – a widely used synthetic chemical – run an increased risk of #HCC, researchers say. ms.spr.ly/6019jdtB7

Surgical de-escalation passes clinical test in low-risk #cervicalcancer #ASCO23 ms.spr.ly/6013gg44V

🆕 meta-analysis of 25 studies dating back to 1948 provides more evidence linking ovarian suppression/ablation in premenopausal women to less recurrence and more survival in the long term after breast cancer. #ASCO23 ms.spr.ly/6013gg7T3

SCLC: Bispecific antibody shows phase 1 promise #ASCO23 ms.spr.ly/6017ggCpz

Chemo avoidance pays off for some women with HER2+ early BC #ASCO23 ms.spr.ly/6018gg7Se

Cross-border U.S.-Mexican collaboration drives up ALL survival #ASCO23 ms.spr.ly/6018gghaq

Groundbreaking new regimen for advanced Hodgkin lymphoma #ASCO23 ms.spr.ly/6017g96i1

Racial disparities in cancer care have been reduced by Medicaid expansion, suggest new nationwide data. #ASCO23 ms.spr.ly/6016g9VR2

A telephone-based weight loss intervention resulted in clinically meaningful weight loss in patients with breast cancer who were overweight and obese. #ASCO23 ms.spr.ly/6015g9Vpb

Oral drug for brain tumor could change treatment landscape ms.spr.ly/6019g9VXt

Up-front pembro plus chemo boost survival in cervical cancer #ASCO23 ms.spr.ly/6013g9Vw9

Ribociclib forestalls recurrence also in early breast cancer #ASCO23 ms.spr.ly/6011g9Ve3

New results in the treatment of advanced ovarian cancer have been welcomed by an expert not involved in the trial, even though the study showed only an improvement in PFS, not yet overall survival. ms.spr.ly/6018g9V5r

#ASCO23 Many patients with locally advanced rectal cancer who do not have high-risk disease can skip radiotherapy to the pelvic area, and instead be treated with chemotherapy alone and then surgery, say researchers reporting results from the PROSPECT trial ms.spr.ly/6017g9VYH

Antibody-drug conjugate changes standard of care for platinum-resistant ovarian cancer ms.spr.ly/6019g9cvz